Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 3,281–3,300 of 17,937 drug recalls

Drug Recall Ongoing Historical recordClass II

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150/5/50MCG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE HCL STOCK SOLUTION 30MG/ML SOLUTION, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE / PHENTOLAMINE INJECTION 150MG / 5MG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 90MG/3MG/29.4MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 75MG/2.5MG/50MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 150MG/10MG/100MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

MITOMYCIN INJECTION 0.375 mg/mL SYR, 0.375 mg/mL solution, 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

METHYLCOBALAMIN PF 1 ML Injection Solution 5,000 MCG/ML Solution, 1 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

LIDOCAINE EPINEPHRINE BUFFERED 2%/1:1000 Solution, 10 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

LIDOCAINE/PHENYLEPHRINE PF SYR 1%/1.5% Solution, 3 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

LAURETH-9 INJ 2% Solution, 30 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

CYCLOSPORIN 0.07% OPTH 0.07% Solution in 10 mL bottles, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution, 0.5 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Drug Recall Ongoing Historical recordClass II

BRILLIANT BLUE G, 0.04% Solution, 2 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

by Pharmacy Plus, Inc. dba Vital Care Compounder

Reason
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Recall initiated
October 7, 2022
Reported by FDA
November 9, 2022
Distribution
AL, LA, MS, and TN

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.